PSK induces apoptosis through the inhibition of activated STAT3 in human esophageal carcinoma cells

International Journal of Oncology

Volumn 41, Issue 1, 2012, Pages 61-66

  Umehara, Seiji ^a   Fujiwara, Hitoshi ^a   Shiozaki, Atsushi ^a   Todo, Momoko ^a   Furutani, Akinobu ^a   Yoneda, Masayuki ^a   Ikai, Atsushi ^a   Tada, Hiroyuki ^a   Komatsu, Shuhei ^a   Ichikawa, Daisuke ^a   Okamoto, Kazuma ^a   Ochiai, Toshiya ^a   Kokuba, Yukihito ^a   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Apoptosis; Bax; Esophageal carcinoma; Polysaccharide K; Signal transducer and activator of transcription 3

Indexed keywords

KRESTIN; POLYSACCHARIDE; PROTEIN BAX; PROTEIN BCL XL; PROTEIN MCL 1; STAT3 PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORIOLACEAE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MUSHROOM; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ESOPHAGEAL NEOPLASMS; HUMANS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-BCL-2; STAT3 TRANSCRIPTION FACTOR;

EID: 84862901928     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1454     Document Type: Article

References (13)

1. Sugimachi K, Inokuchi K, Kuwano H, Kai H, Okamura T and Okudaira Y: Patterns of recurrence after curative resection for carcinoma of the thoracic part of the esophagus. Surg Gynecol Obstet 157: 537-540, 1983. (Pubitemid 14201132)
2. Enzinger PC and Mayer RJ: Esophageal cancer. N Engl J Med 349: 2241-2252, 2003. (Pubitemid 37485141)
3. Tabata T, Hazama S, Yoshino S and Oka M: Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers. Am J Surg 177: 203-208, 1999. (Pubitemid 29183873)
4. Tew WP, Kelsen DP and Ilson DH: Targeted therapies for esophageal cancer. Oncologist 10: 590-601, 2005. (Pubitemid 41429122)
5. Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K and Orita K: Krestin (PSK). Cancer Treat Rev 11: 131-155, 1984. (Pubitemid 16004444)
6. Fisher M and Yang LX: Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res 22: 1737-1754, 2002. (Pubitemid 34839190)
7. Bromberg J and Darnell JE Jr: The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19: 2468-2473, 2000. (Pubitemid 30339202)
8. Krebs DL and Hilton DJ: SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19: 378-387, 2001. (Pubitemid 32900080)
9. Song JI and Grandis JR: STAT signaling in head and neck cancer. Oncogene 19: 2489-2495, 2000. (Pubitemid 30339204)
10. Garcia R, Bowman TL, Niu G, et al: Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20: 2499-2513, 2001. (Pubitemid 32531347)
11. Weber-Nordt RM, Egen C, Wehinger J, et al: Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88: 809-816, 1996. (Pubitemid 26333300)
12. Sumita N, Bito T, Nakajima K and Nishigori C: Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines. Exp Dermatol 15: 291-299, 2006. (Pubitemid 43349070)
13. Suiqing C, Min Z and Lirong C: Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma. J Dermatol 32: 354-360, 2005. (Pubitemid 40874460)